Danahervs.Thermo Fisher Scientific
DHR vs TMO · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Thermo Fisher Scientific is about 1.6× larger than Danaher by market cap; year to date, Thermo Fisher Scientific leads (+14.3% vs −4.6%).
Side by side
| DHR | TMO | |
|---|---|---|
| Market cap | $149B | $237B |
| Price | $217.46 | $651.98 |
| Today | −0.5% | −1.5% |
| Return YTD | −4.6% | +14.3% |
| Return 1Y | +4.7% | +22.8% |
| Since June 26, 2026 | +10.8% | +27.1% |
| P/E | 37.3 | 34.0 |
| P/S | 5.9 | 5.1 |
| P/B | 2.8 | 4.5 |
Data as of 2026-10-08 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
DanaherDHR
Cytiva supplies the equipment biologics are made with; Cepheid runs molecular diagnostics. Danaher owns both, along with a wider set of life science instruments.
Full DHR profile →Thermo Fisher ScientificTMO
Analytical instruments on one side, the reagents and consumables that feed them on the other, sold to research laboratories and pharmaceutical companies. Patheon, its contract manufacturing arm, makes drugs for customers outright.
Full TMO profile →More DHR & TMO comparisons
Other head-to-heads in the Life science tools segment.